State Of Wyoming Eagle Pharmaceuticals, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.34 - $5.6 $45,193 - $75,773	-13,531 Reduced 62.5%	8,118 $45,000
Q1 2024 May 13, 2024	BUY	$4.26 - $6.51 $92,224 - $140,934	21,649 New	21,649 $113,000
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $3,011 - $5,371	114 Added 28.36%	516 $14,000
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $38,908 - $48,423	-943 Reduced 70.11%	402 $18,000
Q1 2022 May 13, 2022	SELL	$44.58 - $52.6 $23,984 - $28,298	-538 Reduced 28.57%	1,345 $67,000
Q4 2021 Feb 11, 2022	BUY	$45.82 - $56.9 $86,279 - $107,142	1,883 New	1,883 $96,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.